mecamylamine has been researched along with Respiratory Insufficiency in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Respiratory Insufficiency: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, Z | 1 |
Bai, X | 1 |
Du, K | 1 |
Huang, Y | 1 |
Wang, W | 1 |
Zhao, Y | 1 |
Pei, Y | 1 |
Mu, J | 1 |
Han, H | 1 |
Hu, S | 1 |
Li, S | 1 |
Dong, H | 1 |
Lu, Y | 1 |
Hou, L | 1 |
Xiong, L | 1 |
1 other study available for mecamylamine and Respiratory Insufficiency
Article | Year |
---|---|
Activation of cholinergic anti-inflammatory pathway contributes to the protective effects of 100% oxygen inhalation on zymosan-induced generalized inflammation in mice.
Topics: Aconitine; Animals; Cytokines; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Lung; Mal | 2012 |